Detalles de la búsqueda
1.
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA).
Eur J Nucl Med Mol Imaging
; 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38740576
2.
Good clinical practice recommendations for the use of PET/CT in oncology.
Eur J Nucl Med Mol Imaging
; 47(1): 28-50, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31637482
3.
Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines.
Eur J Nucl Med Mol Imaging
; 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38693453
4.
Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.
Eur J Nucl Med Mol Imaging
; 45(8): 1279-1288, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29616304
5.
18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis.
Breast Cancer Res
; 19(1): 3, 2017 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28057031
6.
Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.
Eur J Nucl Med Mol Imaging
; 44(7): 1145-1154, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28188325
7.
¹8F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.
Eur J Nucl Med Mol Imaging
; 43(5): 983-993, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26758726
8.
Letter to the Editor: PET/CT in Locally Advanced Breast Cancer: Time for a Guideline Change?
J Natl Compr Canc Netw
; 19(8): xxx, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34416711
9.
Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype.
Radiology
; 277(2): 358-71, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25915099
10.
18FDG-PET/CT Imaging in Breast Cancer Patients with Clinical Stage IIB or Higher : Commentary on "Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer" by Marissa K. Srour et al.
Ann Surg Oncol
; 27(5): 1708-1709, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31933220
11.
Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
Eur J Nucl Med Mol Imaging
; 42(11): 1682-1691, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26140849
12.
Quarter-Century Transformation of Oncology: Positron Emission Tomography for Patients with Breast Cancer.
PET Clin
; 19(2): 147-162, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38177052
13.
Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.
Cancer
; 119(11): 1960-8, 2013 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23504954
14.
Regional Nodal Irradiation in Early-Stage Breast Cancer.
N Engl J Med
; 373(19): 1877-8, 2015 11 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26535518
15.
Performance of FDG PET/CT in the clinical management of breast cancer.
Radiology
; 266(2): 388-405, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23220901
16.
Breast Cancer Systemic Staging (Comparison of Computed Tomography, Bone Scan, and 18F-Fluorodeoxyglucose PET/Computed Tomography).
PET Clin
; 18(4): 503-515, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37268506
17.
FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer.
Eur J Nucl Med Mol Imaging
; 44(9): 1417-1419, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28573331
18.
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer.
Semin Nucl Med
; 52(5): 508-519, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35636977
19.
Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy.
Cancers (Basel)
; 14(5)2022 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35267639
20.
Pathological complete response in breast cancer.
Lancet
; 385(9963): 114, 2015 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25706465